Master Alliance Provisions Guide (MAPGuide)

CEPI – CureVac, Framework Partnering Agreement

  • IP ownership & licensing | Exploitation of results

15. Project Technology – Exploitation

15.1 Partner’s Undertakings. To the extent it is contractually able to do so, Partner shall obtain CEPI’s prior written consent before exploiting, or allowing a Third Party to exploit any of the Project Technology within the Field, provided the exploitation is in conflict with or goes against CEPI’s mission, the CEPI Policies or the provisions of this Clause.

[“Field” means the diagnosis, prevention and treatment of infections caused by the pathogens listed in the WHO R&D blueprint priority (December 2015 or January 2017) as updated from time to time.]

15.2 Right of Reference. The Parties grant each other a right of reference to the regulatory materials relating to the Platform and the Product for use in their respective fields of use.